14 completed, 2 terminated, 1 unknown. 8 Phase 2, 7 Phase 3, 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 8 | Completed 6, Terminated 1, Unknown 1 |
| Phase 3 | 7 | Completed 6, Terminated 1 |
| Phase 1 | 3 | Completed 3 |
Follow NeurogesX: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of NGX-1998 for the Treatment of Postherpetic Neuralgia NGX-1998, Placebo Liquid - Postherpetic Neuralgia, Pain | Phase 2 | Completed | NeurogesX | 183 | 2010-10-01 | 2012-09-10 |
| Study of NGX-4010 With the Use of Open Label Lidocaine (2.5%)/Prilocaine (2.5%) Cream for the Treatment of Postherpetic Neuralgia (PHN) capsaicin 8%, Lidocaine (2.5%)/Prilocaine (2.5%) Cream - Postherpetic Neuralgia | Phase 2 | Completed | NeurogesX | 20 | 2009-06-01 | 2009-09-09 |
| A Study to Investigate the Tolerability and Effects on Epidermal Nerve Fiber Density of Multiple Low-Concentrations of NGX-1998 in Healthy Volunteers Capsaicin Topical Liquid - Pain | Phase 1 | Completed | NeurogesX | 36 | 2008-06-01 | 2009-06-03 |
| Study of NGX-4010 for the Treatment of Painful HIV-Associated Neuropathy NGX-4010, 8% capsaicin patch, 0.04% capsaicin patch - Pain, HIV Infections | Phase 3 | Completed | NeurogesX | 494 | 2006-06-01 | 2011-06-14 |
| Study of NGX-4010 for the Treatment of Postherpetic Neuralgia NGX-4010 - Peripheral Nervous System Diseases, Pain | Phase 3 | Completed | NeurogesX | 400 | 2006-03-01 | 2008-03-06 |
| Effect of NGX-4010 on ENFD and Sensory Function NGX-4010 - Human Volunteers | Phase 1 | Completed | NeurogesX | 36 | 2005-11-01 | 2009-02-16 |
| Study of NGX-4010 for the Treatment of Painful HIV-Associated Neuropathy (HIV-AN) or Postherpetic Neuralgia (PHN) Capsaicin Dermal Patch - Herpes Zoster, Neuralgia | Phase 2 | Completed | NeurogesX | 100 | 2005-08-01 | 2008-03-06 |
| Study of NGX-4010 for the Treatment of Postherpetic Neuralgia NGX-4010 - Peripheral Nervous System Diseases, Pain | Phase 3 | Completed | NeurogesX | 400 | 2005-06-01 | 2008-03-06 |
| Study of NGX-4010 for the Treatment of Painful HIV-Associated Neuropathy Capsaicin Dermal Patch - HIV Infections, Peripheral Nervous System Diseases | Phase 3 | Completed | NeurogesX | 300 | 2003-08-01 | 2008-03-06 |
| Pilot Study of High-Dose Capsaicin Patches to Treat Postherpetic Neuralgia Pain Capsaicin Patch - Neuralgia, Pain | Phase 2 | Completed | NeurogesX | 42 | 2002-03-01 | 2006-02-07 |
| Tolerability of Three Local Anesthetic Formulations in Conjunction With NGX-4010 for the Treatment of Neuropathic Pain Capsaicin Dermal Patch - Herpes Zoster, Neuralgia | Phase 2 | Completed | NeurogesX | 2008-01-11 | ||
| An Open-Label Extension Study of NGX-4010 for the Treatment of Neuropathic Pain Capsaicin Dermal Patch - Herpes Zoster, Neuralgia | Phase 2 | Terminated | NeurogesX | 2005-06-24 | ||
| Study of NGX-4010 for Treatment of Painful HIV-Associated Neuropathy Capsaicin Dermal Patch - HIV Infections, Peripheral Nervous System Diseases | Phase 3 | Terminated | NeurogesX | 2008-03-06 | ||
| Study of Three Capsaicin Dermal Liquid Formulations on Epidermal Nerve Fiber Immunostaining and Sensory Function Capsaicin Dermal Liquid - Pain | Phase 1 | Completed | NeurogesX | 20 | 2008-03-06 | |
| NGX-4010 for the Treatment of Postherpetic Neuralgia Capsaicin Dermal Patch - Herpes Zoster, Neuralgia | Phase 2 / Phase 3 | Completed | NeurogesX | 300 | 2008-03-06 | |
| Controlled Study of NGX-4010 for the Treatment of Postherpetic Neuralgia Capsaicin Dermal Patch - Herpes Zoster, Neuralgia | Phase 3 | Completed | NeurogesX | 150 | 2008-03-06 | |
| Pilot Study of High-Concentration Capsaicin Patches in the Treatment of Painful HIV-Associated Neuropathy Capsaicin Dermal Patch - HIV Infections | Phase 2 | Unknown | NeurogesX | 2007-09-14 |
Pain (15) · Peripheral Nervous System Diseases (11) · Herpes Zoster (9) · Neuralgia (9) · HIV Infections (7) · Neuralgia, Postherpetic (5) · Diabetes Mellitus (2) · Diabetic Neuropathies (2) · Polyneuropathies (2) · Chickenpox (1) · Hyperalgesia (1)
Capsaicin (5) · Lidocaine (1) · Prilocaine (1)
United States (11)
Jeffrey Tobias, MD (5) · Jeff Tobias, MD (2) · David M Simpson, MD (1) · John A Jermano (1) · Trudy F Vanhove, MD (1) · Trudy Vanhove, MD, PhD, MBA (1) · William R. Kennedy, MD (1)
PMID 23351618, PMID 18541884, PMID 18977178, PMID 20400377, PMID 20538187, PMID 20937130, PMID 21087403, PMID 21612836, PMID 22067661, PMID 22182397, PMID 23446088